Atea Pharmaceuticals, Inc. Public Float
Atea Pharmaceuticals, Inc. (AVIR) had Public Float of $262.60 million as of 2025-06-30, per its 10-K filed 2026-03-05.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-05
- 2025-06-30: Entity Public Float $262.60M.
- 2024-06-28: Entity Public Float $253.00M.
- 2023-06-30: Entity Public Float $283.70M.
- 2022-06-30: Entity Public Float $537.28M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $262.60M 10-K · filed 2026-03-05 |
| 2024-06-28 | $253.00M 10-K · filed 2025-03-06 |
| 2023-06-30 | $283.70M 10-K · filed 2024-02-28 |
| 2022-06-30 | $537.28M 10-K · filed 2023-02-28 |
| 2021-06-30 | $1.62T 10-K · filed 2022-02-28 |
| 2020-06-30 | $0.00 10-K · filed 2021-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 |